Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.1050
0.00 (0.00%)
Oct 9, 2026, 3:05 PM AEST
Vectus Biosystems Market Cap
Vectus Biosystems has a market cap or net worth of 6.53 million as of October 9, 2026. It is the 45,375th most valuable company in the world and the 1,476th biggest in Australia. Its market cap has increased by 65.44% in one year.
Market Cap
6.53M
Enterprise Value
3.56M
Revenue
2.77M
Global Rank
Country Rank
#1,476 Australia
PE Ratio
3.74
ChartMarket Cap Chart
Since February 23, 2016, Vectus Biosystems's market cap has decreased from 36.22M to 6.53M, a decrease of -81.97%. That is a compound annual growth rate of -14.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 6.53M | -32.11% |
| Dec 31, 2025 | 9.62M | 134.56% |
| Dec 23, 2024 | 4.10M | -74.31% |
| Dec 29, 2023 | 15.96M | -58.89% |
| Dec 30, 2022 | 38.83M | -15.39% |
| Dec 31, 2021 | 45.89M | 20.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 12.27M |
| AdAlta | 11.24M |
| Invex Therapeutics | 8.27M |
| Bio-Gene Technology | 7.01M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Biotron | 5.57M |
| Tissue Repair | 5.14M |